Kintara Therapeutics (KTRA) has released an update.
Kintara Therapeutics, Inc. has officially ended its use of the at-the-market (ATM) offering as per the agreement with A.G.P./Alliance Global Partners and has also ceased using its equity facility with Lincoln Park Capital Fund, LLC. This marks a strategic financial move for the company as it progresses forward.
For further insights into KTRA stock, check out TipRanks’ Stock Analysis page.
